When Forgetfulness During Menopause Feels Scary

You walk into a room and forget why you went there.

A familiar name suddenly disappears from your mind.

You reread the same paragraph three times because concentrating feels harder than it used to.

For many women in their 40s and 50s, these experiences can be unsettling—especially if a mother, grandmother, or another loved one has experienced Alzheimer’s disease or dementia.

One of the most common questions women ask during perimenopause is:

“Is this normal brain fog, or is something happening to my brain?”

The reassuring answer is that cognitive complaints such as forgetfulness, difficulty concentrating, and trouble retrieving words are very common during the menopause transition. The Menopause Society notes that these changes are usually mild, and dementia during midlife remains uncommon.

That does not mean the symptoms are imaginary.

Menopause is more than the end of menstrual cycles. It is a major biological transition involving the brain, cardiovascular system, bones, metabolism, sleep, temperature regulation, and multiple hormone-sensitive tissues throughout the body.

Estrogen is part of that story.

As estrogen levels begin fluctuating and eventually decline, the environment in which the brain has operated for decades changes. Researchers are increasingly interested in how this transition may influence memory, metabolism, mood, sleep, and long-term neurological health.

That is where the relationship between estrogen, menopause, and Alzheimer’s disease becomes both fascinating and complicated.

Estrogen Is Much More Than a Reproductive Hormone

Most people first learn about estrogen in the context of periods, pregnancy, and reproduction.

But estrogen receptors—the cellular structures that allow estrogen to deliver signals—are found throughout the body, including the brain.

One of the primary forms of estrogen during the reproductive years is estradiol.

Estradiol interacts with areas of the brain involved in:

• Memory

• Attention

• Mood

• Sleep

• Temperature regulation

• Learning

• Energy metabolism

In other words, estrogen does not simply help regulate the menstrual cycle.

It participates in how the brain communicates and functions.

For patients, one useful way to picture estrogen is as part of the brain’s support system rather than an on/off button.

It influences several processes occurring simultaneously.

Estrogen and Brain Energy

The brain requires an enormous amount of energy.

Although it represents only a small percentage of total body weight, it consumes a large share of the glucose—or blood sugar—the body uses for fuel.

Research suggests estrogen helps influence how efficiently brain cells use glucose.

Glucose metabolism simply means the process through which cells convert glucose into usable energy.

When estrogen levels change during menopause, researchers have observed corresponding changes in brain energy metabolism. This does not mean that the brain suddenly “shuts down,” but it may help explain why some women experience changes in concentration, mental stamina, and memory during this period.

Studies examining menopause and the brain have identified changes in brain structure, connectivity, and energy use during the menopausal transition.

Why Does Menopause Cause Brain Fog?

“Brain fog” is not a medical diagnosis.

It is a patient-friendly term describing symptoms such as:

• Forgetfulness

• Difficulty concentrating

• Slower word recall

• Feeling mentally scattered

• Trouble multitasking

• Reduced mental sharpness

These symptoms can appear during perimenopause, when hormone levels may fluctuate significantly from month to month.

Importantly, estrogen is only one factor.

Sleep disruption, hot flashes, night sweats, stress, anxiety, depression, medications, thyroid problems, nutritional deficiencies, insulin resistance, and other health conditions can also affect cognitive performance.

That is why a thorough clinical evaluation matters.

The Menopause Society reports that measurable changes in verbal memory can occur during the menopause transition, although these changes are generally small and are not equivalent to dementia.

For many patients, simply knowing that these symptoms can be part of menopause provides tremendous relief.

What Does Alzheimer’s Disease Actually Do to the Brain?

To understand why researchers study estrogen, we need to understand a little about Alzheimer’s disease.

Alzheimer’s is a progressive neurological disease that damages brain cells over time.

Two features receive significant attention in research:

Amyloid-beta plaques

Amyloid-beta is a protein fragment.

In Alzheimer’s disease, abnormal amounts can accumulate between brain cells, creating deposits called plaques.

Tau tangles

Tau is another protein normally involved in maintaining the internal structure of neurons.

In Alzheimer’s disease, tau proteins can become abnormal and form twisted structures known as tangles inside brain cells.

Together with inflammation, vascular disease, genetic factors, and other biological changes, these processes interfere with communication between neurons and eventually contribute to brain-cell death.

Researchers are studying whether the hormonal changes of menopause influence some of these processes.

The answer is not yet simple.

Why Are Researchers So Interested in Estrogen and Alzheimer’s?

Women make up a substantial proportion of people living with Alzheimer’s disease.

Age is a major reason because women, on average, live longer.

But researchers have also investigated biological differences involving genetics, metabolism, immune function, cardiovascular health, and reproductive hormones.

Estrogen has attracted particular interest because of its influence on:

• Brain-cell signaling

• Energy metabolism

• Blood vessels

• Inflammation

• Synaptic function

A synapse is the connection point where one nerve cell communicates with another.

You can think of synapses as the communication network of the brain.

Changes in estrogen signaling may influence how efficiently portions of this network function.

Research led by Mosconi and colleagues has also demonstrated that menopause is associated with measurable changes in brain metabolism and structure, reinforcing the idea that menopause should be viewed partly as a neurological transition—not simply a reproductive one.

That finding is important.

It does not, however, mean that menopause causes Alzheimer’s disease.

Is Estrogen Decline Like Flipping a Switch?

This metaphor can be helpful—as long as we use it carefully.

Rather than imagining estrogen as a single Alzheimer’s switch, imagine the brain as a large city.

Before menopause, estrogen participates in multiple systems that help keep that city functioning:

The power grid supplies energy.

The transportation system moves information.

Maintenance crews repair damage.

Emergency services control inflammation.

Communication networks allow different neighborhoods to work together.

During menopause, the hormonal environment changes.

It is as though the city suddenly has to operate under a new energy plan.

Some systems may become less efficient temporarily while the brain adapts.

That transition may contribute to symptoms such as brain fog, sleep disruption, mood changes, and difficulty concentrating.

But the city does not simply turn off.

The brain adapts.

Lifestyle, genetics, cardiovascular health, sleep, metabolic health, and numerous other factors continue influencing how well it functions over the following decades.

Early or Surgical Menopause Deserves Special Attention

One area where the estrogen-dementia relationship becomes especially important involves women who experience menopause significantly earlier than expected.

Surgical menopause occurs when both ovaries are removed before natural menopause.

This procedure is called a bilateral oophorectomy.

Because the ovaries are a major source of estrogen before menopause, removing them can cause estrogen levels to fall abruptly rather than gradually.

Research has associated early loss of ovarian function with increased long-term health risks, including neurological concerns.

Rocca and colleagues have reported an association between premenopausal oophorectomy and later cognitive impairment or dementia, particularly when estrogen was not continued until approximately the natural age of menopause.

For practitioners, this distinction is important.

The risk-benefit conversation for a 42-year-old experiencing surgical menopause can be very different from the discussion with a woman first considering hormone therapy at age 68.

The Timing Hypothesis: An Important Idea, but Not a Proven Dementia Treatment

Researchers have spent years studying what is known as the timing hypothesis or critical window hypothesis.

The idea is relatively straightforward:

Hormone therapy started near menopause may affect the brain differently than hormone therapy first started many years after menopause.

There is biological plausibility for this theory, and observational studies have sometimes suggested better outcomes among women who began hormone therapy closer to menopause.

However, this is where online health information often becomes too confident.

It is not currently proven that starting HRT within 10 years of menopause prevents Alzheimer’s disease.

Randomized trials have generally not demonstrated a clear cognitive benefit from hormone therapy in naturally postmenopausal women.

A 2026 report highlighted by The Menopause Society also found that hormone therapy started within 10 years of menopause was not associated with better global cognitive performance, supporting existing recommendations that hormone therapy should not be prescribed solely for dementia prevention.

A 2024 review likewise concluded that the effects of menopausal hormone therapy on dementia remain uncertain and may vary according to age, menopause type, symptoms, hormone formulation, and individual risk factors.

That nuance matters.

What Did the Women’s Health Initiative Actually Show?

Few studies influenced public opinion about hormone therapy as dramatically as the Women’s Health Initiative, or WHI.

One part of the research program, called the Women’s Health Initiative Memory Study (WHIMS), investigated dementia and cognition.

The results were concerning.

Women age 65 and older who received conjugated equine estrogen combined with medroxyprogesterone acetate experienced a higher incidence of probable dementia compared with placebo.

The estrogen-alone arm also did not demonstrate dementia prevention in women who began treatment between ages 65 and 79.

Those findings remain important.

However, they should not automatically be generalized to every woman considering menopause therapy today.

Why?

Because the WHIMS participants were 65 or older when therapy was initiated. That is very different from beginning treatment during perimenopause or shortly after menopause for symptoms such as hot flashes and night sweats.

Formulations and delivery methods also differ among modern treatment options.

But we should not swing too far in the opposite direction either.

It would be inaccurate to say the WHI was simply “wrong” or that newer bioidentical hormones have been proven to prevent dementia.

They have not.

A better conclusion is:

Age, timing, formulation, route of administration, medical history, and treatment indication all matter when assessing hormone therapy.

What Does “Bioidentical” Actually Mean?

The word bioidentical is often misunderstood.

A bioidentical hormone has the same molecular structure as a hormone naturally produced by the human body.

FDA-approved examples include certain forms of:

• 17β-estradiol

• Micronized progesterone

Estradiol can be delivered through patches, gels, sprays, or oral preparations depending on the patient and treatment plan.

Micronized progesterone may be required for women who still have a uterus when systemic estrogen is prescribed because estrogen by itself can stimulate the uterine lining.

For clinicians and patients alike, the important point is that “bioidentical” does not automatically mean safer, better, or neuroprotective.

Treatment selection should be based on evidence, medical history, symptoms, risks, and the individual patient.

Does HRT Help Brain Fog?

This answer requires some nuance.

Hormone therapy is highly effective for certain menopause symptoms, particularly hot flashes and night sweats.

If hot flashes are waking a woman repeatedly throughout the night, treating those symptoms may improve sleep.

Better sleep can improve:

• Concentration

• Mood

• Energy

• Memory performance

• Overall quality of life

So a patient may genuinely report feeling mentally clearer after beginning appropriate menopause treatment.

That does not necessarily mean estrogen is directly preventing Alzheimer’s disease.

It may mean multiple menopause symptoms that were interfering with cognitive function have improved.

For naturally menopausal women, current guidance does not recommend hormone therapy specifically for the purpose of improving cognition.

That distinction strengthens—not weakens—the medical conversation.

What About APOE4?

Some patients are now asking about APOE4, especially as consumer genetic testing becomes more common.

APOE stands for apolipoprotein E.

Everyone carries versions of this gene, but one version—APOE ε4—is associated with increased risk of developing Alzheimer’s disease.

Having APOE4 does not mean someone will develop Alzheimer’s.

Likewise, not having APOE4 does not guarantee protection.

Research is investigating whether genetic differences such as APOE status change how women respond neurologically to menopause or hormone therapy.

At this point, however, APOE testing should not be used as a simple formula such as:

“APOE4 positive = start HRT.”

The relationship is far more complicated.

Genetic information should be interpreted alongside family history, cardiovascular health, metabolic health, symptoms, age, and other risk factors.

Protecting Your Brain During Menopause Requires More Than Hormones

Perhaps the most important message for patients is this:

Brain health is multifactorial.

Estrogen matters, but so do many other factors.

Some of the strongest strategies for supporting long-term cognitive health include:

Protect Your Cardiovascular Health

What is good for the heart is often good for the brain.

Monitor and appropriately manage:

• Blood pressure

• Cholesterol

• Blood sugar

• Insulin resistance

• Smoking exposure

The brain depends on healthy blood vessels to receive oxygen and nutrients.

Exercise Regularly

Both aerobic exercise and resistance training support brain health.

Exercise can improve cardiovascular function, insulin sensitivity, mood, sleep, and physical strength.

Resistance training also helps combat another major menopause-related concern: loss of lean muscle and bone density.

Protect Your Sleep

Sleep is not optional brain maintenance.

Chronic insomnia and repeated sleep disruption can affect attention, mood, memory, and metabolic health.

Hot flashes and night sweats are common reasons sleep becomes fragmented during menopause.

Treating the underlying menopause symptoms may therefore have benefits that extend well beyond comfort.

Eat for Metabolic and Cardiovascular Health

Dietary patterns resembling the Mediterranean diet have consistently been associated with healthier cardiovascular and cognitive aging.

Think:

• Vegetables

• Fruit

• Legumes

• Nuts

• Fish

• Whole grains

• Olive oil

• Adequate protein

Rather than relying on a single “brain supplement,” focus on the entire nutritional pattern.

Stay Mentally and Socially Engaged

Learning new skills, maintaining meaningful relationships, reading, working, volunteering, solving problems, and participating in social activities all keep the brain engaged.

Recent research has continued to highlight associations between social isolation and subjective cognitive decline in perimenopausal women.

When Should Memory Changes Be Evaluated?

Brain fog during menopause is common.

But significant or worsening cognitive symptoms should not automatically be blamed on hormones.

Talk with a healthcare professional if memory problems:

• Are rapidly worsening

• Interfere with work or daily responsibilities

• Cause difficulty managing finances

• Lead to getting lost in familiar places

• Cause major personality or behavioral changes

• Are noticed consistently by family members

• Continue despite improved sleep and menopause symptoms

Other medical conditions can mimic menopause-related brain fog.

These may include:

• Thyroid disorders

• Vitamin B12 deficiency

• Anemia

• Depression

• Anxiety

• Sleep apnea

• Medication side effects

• Diabetes

• Neurological disease

A comprehensive evaluation helps determine what actually needs treatment.

The Steel City HRT & Weight Loss Perspective

At Steel City HRT & Weight Loss, menopause care is not about chasing a single hormone number.

It is about understanding the whole patient.

Symptoms, medical history, reproductive history, cardiovascular health, sleep, metabolic health, family history, medications, lifestyle, and personal treatment goals all matter.

For an appropriate candidate experiencing bothersome menopause symptoms, menopausal hormone therapy may be one component of a comprehensive care plan.

But treatment should always begin with an individualized risk-benefit conversation.

Hormone therapy should not be sold as a guaranteed way to prevent Alzheimer’s disease.

What it can do exceptionally well in appropriately selected patients is treat important menopause symptoms—and helping women sleep better, function better, maintain bone health, and navigate the menopause transition successfully can have meaningful effects on overall health and quality of life.

Menopause Changes the Brain—but It Does Not Determine Your Future

The decline in estrogen during menopause represents a significant biological transition.

It influences systems involved in memory, mood, temperature regulation, energy metabolism, and sleep.

That helps explain why so many women describe menopause as feeling like someone suddenly changed the settings inside their brain.

But estrogen is not a simple Alzheimer’s switch.

Menopause does not mean dementia is beginning.

Brain fog does not automatically mean Alzheimer’s.

And HRT does not guarantee dementia prevention.

The science is more interesting—and more empowering—than any of those simplified messages.

Midlife gives women an important opportunity to examine cardiovascular health, metabolic health, sleep, exercise, nutrition, menopause symptoms, family history, and hormone needs together.

Instead of waiting until something feels seriously wrong, menopause can become a moment to establish a healthier foundation for the decades ahead.

That is the real opportunity.

Ready to Understand What Your Symptoms Are Telling You?

If brain fog, disrupted sleep, hot flashes, mood changes, declining energy, or other menopause symptoms are affecting your quality of life, you do not have to simply accept them as “getting older.”

At Steel City HRT & Weight Loss, Jeremiah works with patients to evaluate symptoms, health history, appropriate laboratory information, and individual risk factors before discussing treatment options.

The goal is not to promise a cure for aging or Alzheimer’s disease.

The goal is to help you understand what is changing in your body and make informed, medically supervised decisions about your health.

Call Steel City HRT & Weight Loss at 719-669-4223 or visit SteelCity-HRT.com to schedule a consultation.

References

Brinton, R. D. (2008). The healthy cell bias of estrogen action: Mitochondrial bioenergetics and neurological implications. Trends in Neurosciences, 31(10), 529–537.

Maki, P. M., & Henderson, V. W. (2016). Hormone therapy, dementia, and cognition: The Women's Health Initiative 10 years on. Climacteric, 19(5), 439–446.

Mosconi, L., Rahman, A., Diaz, I., et al. (2018). Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition. Scientific Reports, 8, 708.

Rocca, W. A., Grossardt, B. R., & Shuster, L. T. (2011). Oophorectomy, estrogen, and dementia: A 2011 update. Maturitas, 69(2), 191–194.

Shumaker, S. A., Legault, C., Rapp, S. R., et al. (2003). Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative Memory Study. JAMA, 289(20), 2651–2662.

The Menopause Society. Perimenopause and cognitive health patient education resources.

The Menopause Society. Hormone therapy and menopause patient education resources.

The Menopause Society. Menopause and brain health professional resources.